These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38037270)

  • 1. Estimating average treatment effects for clustered RCTs with recruitment bias.
    Schochet PZ
    Stat Med; 2024 Feb; 43(3):452-474. PubMed ID: 38037270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model misspecification and bias for inverse probability weighting estimators of average causal effects.
    Waernbaum I; Pazzagli L
    Biom J; 2023 Feb; 65(2):e2100118. PubMed ID: 36045099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Viable Alternative When Propensity Scores Fail: Evaluation of Inverse Propensity Weighting and Sequential G-Estimation in a Two-Wave Mediation Model.
    Valente MJ; MacKinnon DP; Mazza GL
    Multivariate Behav Res; 2020; 55(2):165-187. PubMed ID: 31220937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-Adaptive Selection of the Propensity Score Truncation Level for Inverse-Probability-Weighted and Targeted Maximum Likelihood Estimators of Marginal Point Treatment Effects.
    Gruber S; Phillips RV; Lee H; van der Laan MJ
    Am J Epidemiol; 2022 Aug; 191(9):1640-1651. PubMed ID: 35512316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.
    Cheng C; Li F; Thomas LE; Li FF
    Am J Epidemiol; 2022 May; 191(6):1140-1151. PubMed ID: 35238335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric and nonparametric propensity score estimation in multilevel observational studies.
    Salditt M; Nestler S
    Stat Med; 2023 Oct; 42(23):4147-4176. PubMed ID: 37532119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score weighting for covariate adjustment in randomized clinical trials.
    Zeng S; Li F; Wang R; Li F
    Stat Med; 2021 Feb; 40(4):842-858. PubMed ID: 33174296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variance reduction in the inverse probability weighted estimators for the average treatment effect using the propensity score.
    Liao J; Rohde C
    Biometrics; 2022 Jun; 78(2):660-667. PubMed ID: 33715153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIPW: An R Package for Augmented Inverse Probability-Weighted Estimation of Average Causal Effects.
    Zhong Y; Kennedy EH; Bodnar LM; Naimi AI
    Am J Epidemiol; 2021 Dec; 190(12):2690-2699. PubMed ID: 34268567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On variance estimation of the inverse probability-of-treatment weighting estimator: A tutorial for different types of propensity score weights.
    Kostouraki A; Hajage D; Rachet B; Williamson EJ; Chauvet G; Belot A; Leyrat C
    Stat Med; 2024 Jun; 43(13):2672-2694. PubMed ID: 38622063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting for interactions and complex inter-subject dependency in estimating treatment effect in cluster-randomized trials with missing outcomes.
    Prague M; Wang R; Stephens A; Tchetgen Tchetgen E; DeGruttola V
    Biometrics; 2016 Dec; 72(4):1066-1077. PubMed ID: 27060877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On Variance of the Treatment Effect in the Treated When Estimated by Inverse Probability Weighting.
    Reifeis SA; Hudgens MG
    Am J Epidemiol; 2022 May; 191(6):1092-1097. PubMed ID: 35106534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step estimation in ratio-of-mediator-probability weighted causal mediation analysis.
    Bein E; Deutsch J; Hong G; Porter KE; Qin X; Yang C
    Stat Med; 2018 Apr; 37(8):1304-1324. PubMed ID: 29322536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study.
    Huang S; Fiero MH; Bell ML
    Clin Trials; 2016 Aug; 13(4):445-9. PubMed ID: 27094487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.